Image
|
Figure Caption
Fig. 1 Ombuoside protects HEI-OC1 cells from cisplatin toxicity. A. HEI-OC1 cells were treated with varying concentrations of ombuoside doses for 24 h. Cell viability was analyzed by cell counting kit-8 (CCK-8) and compared with untreated cells, N ? 5 B. HEI-OC1 cells were pre-treated with varying concentrations of ombuoside for 2 h and then co-treated with 30 ?mol/L cisplatin for 24 h. Cell viability was evaluated by CCK-8 and compared with cells treated with cisplatin alone, N ? 4. Data are presented as mean ± SEM. ?P ? 0.05, ??P ? 0.01, ???P ? 0.001, and ????P ? 0.0001.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Heliyon